{
  "documentMetadata": {
    "title": "Prevention of Recurrent UTI, Female",
    "sourceFile": "Prevention of Recurrent UTI, Female.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Recurrent urinary tract infection (UTI) in women: cystitis, urethritis.",
        "Young person: ≥ 3 culture-positive episodes/year.",
        "Post-menopausal person: ≥3 culture + symptomatic UTIs in 1 year or 2 UTIs in 6 months."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "E. coli",
        "Enterobacterales",
        "Enterococcus sp.",
        "Staph. saprophyticus"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Pre-menopausal woman:"
        },
        {
          "type": "list",
          "items": [
            "Avoid spermicide",
            "Increase fluid intake (additional 1.5L/day) (JAMA Intern Med 2018; 178:1509)",
            "Methenamine hippurate 1gm po bid (Cochrane Database Syst Rev 2012; BMJ 2022;376: e068229)"
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Post-coitol antibiotics: Single dose immediately after intercourse (JAMA 1993; 264: 703):"
            },
            {
              "type": "list",
              "items": [
                "Nitrofurantoin 100 mg",
                "TMP-SMX 80mg/400 mg",
                "Trimethoprim 100 mg",
                "Cephalexin 250 mg"
              ]
            }
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Post-menopausal woman:"
        },
        {
          "type": "list",
          "items": [
            "Intravaginal estrogen: 0.5 mg Estriol cream intravaginal daily x 2 weeks and then twice weekly as maintenance (N Engl J Med 1993; 329: 753)",
            "Increase fluid intake (additional 1.5L/day) (JAMA Intern Med 2018; 178:1509)",
            "Methenamine hippurate 1gm po bid (Cochrane Database Syst Rev 2012)"
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Post-coitol antibiotics: Single dose immediately after intercourse (JAMA 1993; 264: 703):"
            },
            {
              "type": "list",
              "items": [
                "Nitrofurantoin 100 mg",
                "TMP-SMX 80mg/400 mg",
                "Trimethoprim 100 mg",
                "Cephalexin 250 mg"
              ]
            }
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "In persons with recurrent UTIs who have failed strategies above and have significant reduced quality of life and/or repeat hospitalizations, consider a limited time trial of antibiotic prophylaxis with an antibiotic active against the predominant infecting pathogen. (Lancet Infect Dis 2018; 18:957). Providers need to balance risk of developing antibiotic resistant pathogens with benefit. Regimens could include one of the following:"
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Daily regimens:"
            },
            {
              "type": "list",
              "items": [
                "Nitrofurantoin 50-100 mg once daily",
                "Trimethoprim 100 mg daily",
                "TMP-SMX 40mg/200mg once daily or 3x weekly",
                "Cephalexin 250 mg daily"
              ]
            }
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Weekly regimen:"
            },
            {
              "type": "drugRegimen",
              "regimenData": {
                "intent": "prophylaxis",
                "strengthOfRecommendation": "Alternative",
                "components": [
                  {
                    "drug": "Fosfomycin",
                    "dose": "3gm",
                    "frequency": "once weekly"
                  },
                  {
                    "drug": "Cefixime",
                    "connector": "+"
                  },
                  {
                    "drug": "Amoxicillin-clavulanate",
                    "connector": "or"
                  },
                  {
                    "drug": "TMP-SMX",
                    "connector": "or"
                  }
                ],
                "notes": "(Clin Infect Dis 71;3128: 2021)"
              }
            }
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Strategies which have NOT demonstrated efficacy to prevent UTIs:",
        "Cranberry products (JAMA 2016;316:1873; JAMA 2016;316:1879)",
        "Oral probiotics (Arch Int Med 2012; 172:204)",
        "Intravaginal probiotics may be useful: a randomized placebo controlled trial of a once weekly Lactobacillus crispatus probiotic vaginal suppository for 10 weeks showed a 50% reduction in recurrences with the probiotic (Clin Infect Dis 52:1212, 2011) and another study (Clin Infect Dis 2024) demonstrated reduced recurrence of UTIs at 4 months in women who received regimens including intravaginal lactobacillus when compared with those who received placebo or oral lactobacillus alone.",
        "Consider urologic evaluation/imaging if hematuria without dysuria, elevated serum creatinine, recurrent Proteus infections, or incontinence/retention",
        "References: New Engl J Med 366:1028, 2012; Clin Infect Dis 52: e103-120, 2011 (IDSA-ESCMID Guidelines)."
      ]
    }
  ]
}